Delivery Order SPE2DB20D3103-SPE2DB25FM7Q9

Award Date 2/19/25
Potential Completion Date 2/20/25
Potential Value $8.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $9,708.94 for the supply of Humulin R 500 unit/mL KwikPen 3mL. The contract has an ultimate completion date of November 18, 2024 and is a Firm Fixed Price arrangement. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award is a delivery order valued at $24,203.68 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of Humulin R 500 unit/ml KwikPen 3ml, a specialty pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of February 21, 2024. AmerisourceBergen is the prime contractor and holds a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,903.96 fixed-price delivery order is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a pharmaceutical product. The contract has an ultimate completion date of June 26, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,270.71 firm fixed-price delivery order is for the supply of Humulin R 500 unit/mL Kwikpen 3mL, a type of insulin medication. The contract has an ultimate completion date of February 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,236.32 firm fixed-price delivery order is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a specialty pharmaceutical product. The contract has an ultimate completion date of May 10, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,298.58, is a delivery order for the supply of "HUMULIN R 500 UNIT/ML KWIKPEN 3ML", a pharmaceutical product. The contract has an ultimate completion date of December 30, 2024 and is a firm fixed price agreement. This award is part of a larger Indefinite Delivery Contract (IDC) valued...
This federal contract award, valued at $5,218.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Humulin R 500 Unit/ML Kwikpen 3ML. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is September 16, 2024. The contract is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with...
This federal contract award, valued at $8,330.69, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a pharmaceutical product, and has a completion date of June 26, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award is for the delivery of Humulin R 500 Unit/ML Kwikpen 3ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $20,358.89 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 17, 2024, with a completion date of December 18, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,999.29, is for the delivery of Humulin R 500 Unit/mL Kwikpen 3mL, a specialty medication used for diabetes management. The contract is a Firm Fixed Price Delivery Order with a completion date of November 1, 2024. It is not designated as a set-aside contract, indicating open competition....
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FM7Q9
    Delivery Order

This federal contract award, valued at $8,204.29, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Humulin R 500 Unit/mL Kwikpen 3mL, a specialty pharmaceutical product.

The contract is a Firm Fixed Price Delivery Order with a completion date of February 20, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. In addition, the company maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 5/21/25, 10:27 AM